Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 33 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.Karnon, J.; Peters, J.; Chilcott, J.; McGoogan, E.; Brewer, N.
2018Estimating the reference incremental cost-effectiveness ratio for the Australian health systemEdney, L.; Haji Ali Afzali, H.; Cheng, T.; Karnon, J.
2018Model structuring for economic evaluations of new health technologiesHaji Ali Afzali, H.; Bojke, L.; Karnon, J.
2003A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patientsKarnon, J.; Jones, T.
2013A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in AustraliaHajiali Afzali, H.; Gray, J.; Beilby, J.; Holton, C.; Karnon, J.
2012Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practiceKarnon, J.; Caffrey, O.; Pham, C.; Grieve, R.; Ben-Tovim, D.; Hakendorf, P.; Crotty, M.
2015Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility spaceMcCaffrey, N.; Agar, M.; Harlum, J.; Karnon, J.; Currow, D.; Eckermann, S.; Feenstra, T.
2015Cost-value analysis and the SAVE: a work in progress, but an option for localised decision making?Karnon, J.; Partington, A.
2012Lifetime cost-utility analyses of deferasirox in beta-thalassaemia patients with chronic iron overload: A UK perspectiveKarnon, J.; Tolley, K.; Vieira, J.; Chandiwana, D.
2013A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetesHajiali Afzali, H.; Gray, J.; Beilby, J.; Holton, C.; Banham, D.; Karnon, J.